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Abstract
This study investigates the use of a mechanically-swept 3D ultrasound (3D-US) probe for 
soft-tissue  displacement  monitoring  during  prostate  irradiation  with  emphasis  on 
quantifying the accuracy relative to CyberKnife® x-ray fiducial tracking. 
An US phantom, implanted with x-ray fiducial markers was placed on a motion platform 
and translated  in  3D using  5  real  prostate  motion  traces acquired  using  the  Calypso 
system. Motion traces were representative of all types of motion as classified by studying 
Calypso data for 22 patients. The phantom was imaged using a 3D swept linear-array 
probe (to mimic trans-perineal imaging) and, subsequently, the kV x-ray imaging system 
on CyberKnife. A 3D cross-correlation block matching algorithm was used to track speckle 
in the ultrasound data. Fiducial and US data were each compared with known phantom 
displacement.
Trans-perineal 3D-US imaging could track superior-inferior (SI) and anterior-posterior (AP) 
motion  to  ≤  0.81  mm root-mean-square  error  (RMSE)  at  a  1.7  Hz  volume rate.  The 
maximum  kV  x-ray  tracking  RMSE  was  0.74  mm,  however  the  prostate  motion  was 
sampled at a significantly lower imaging rate (mean: 0.04 Hz). Initial elevational (RL) US 
displacement estimates showed reduced accuracy but could be improved (RMSE < 2.0 
mm) using a correlation threshold in the ultrasound tracking code to remove erroneous 
inter-volume displacement estimates. 
Mechanically-swept  3D-US can accurately track the major components of  intra-fraction 
prostate motion accurately but exhibits some limitations. The largest US RMSE was for 
elevational (right-left) motion. For the AP and SI axes, accuracy was sub-millimetre. It may 
be feasible to track prostate motion in 2D only. 3D-US also has potential for improvement 
for  high  tracking  accuracy  in  all  circumstances.  It  would  be  advisable  to  use  US  in 
conjunction with a small (~ 2.0 mm) centre-of-mass displacement threshold in which case 
it would be possible to take full advantage of the accuracy and high imaging rate capability.
1. Introduction
During  radiation  therapy  it  is  known  that  the  prostate,  as  delineated  on  computed 
tomography  (CT)  images,  can  undergo  significant  displacements  (~10  mm)  during 
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treatment, requiring the use of an additional treatment margin to account for this intra-
fraction  motion  (Webb  2006,  Korreman  2012).  Radiation  therapy  (RT)  of  prostate 
carcinoma  is  usually  delivered  via  external  mega-voltage  x-ray  beams.  Treatment  is 
typically  delivered using a standard 10 mm planning target  volume (PTV)  margin and 
fractionation regime (e.g. 78 Gy in 2 Gy fractions) (Fowler et al. 2003). It has however  
been proposed that the cell survival curve following RT for prostate cancer may be strongly 
curved (with the ratio of fit  coefficients, alpha/beta ~ 1.5) (Fowler et al.  2001, Bentzen 
2005).  If  the alpha/beta ratio is  approximately  equal  to  that  of  late responding normal  
tissue, a hypo-fractionated radiation treatment regime would increase the therapeutic gain 
of  radiotherapy  (Miles  and  Lee  2008).  Unfortunately,  potential  benefits  of  hypo-
fractionation may not be fully realised due to the need for large PTV margins to account for 
prostate motion. With increased accuracy of prostate localisation (Letourneau et al. 2004)  
and tracking  (Willoughby et  al.  2006)  comes the  prospect  of  increasing  tumour  dose, 
reducing PTV margins (Litzenberg et  al.  2006) and minimising toxicity  to surrounding 
organs  (Huang  et  al.  2002).  In  turn  this  may  help  to  elucidate  the  benefits  of  hypo-
fractionation.
The  ability  to  visualise  the  prostate  in  three  dimensions  and  its  position  relative  to 
surrounding healthy tissues has become essential. Motion of the prostate is influenced by 
a number of factors including variability in rectal activity (Roeske et al. 1995, Stillie et al.  
2009), bladder filling (Ten haken et al. 1991) and clenching of the pelvic floor muscles 
(Padhani et al. 1999). Image-guided radiotherapy for the prostate involves one of many 
methods of identifying the location of the prostate, followed by adjustment of the treatment 
fields to target the prostate. Methods of monitoring prostate position have largely relied on 
identification  of  metal  fiducials  via  kV  x-ray  imaging  (Jaffray  et  al.  2002)  and,  more 
recently, using implanted electromagnetic fiducials (Willoughby et al. 2006). 
The  CyberKnife® robotic  radio-surgery  system (Accuray,  CA,  USA)  uses  a  robotically  
mounted 6 MV linear accelerator to deliver hypo-fractionated treatments (Kilby et al. 2010). 
A typical prostate treatment consists of a large number (~100) of small ( : 20⌀  – 30 mm) 
conformal beams. Two kV x-ray tubes and paired flat-panel detectors are use to localise 
and track three or more gold fiducial  markers implanted in the prostate.  The specified 
maximum imaging frequency is 0.2 Hz. A typical prostate plan requires ~ 45 minutes to 
deliver 5 Gy per fraction, with most of the time occupied by robot positioning and fiducial 
localisation (imaging). CyberKnife has show promise in terms of superior target coverage 
and rectum and bladder sparing when compared to prostate intensity modulated radiation 
therapy (King et al. 2003). However when a mean imaging period of 30 – 60 seconds is  
used, there will invariably be some occasions when a treatment beam misses the target 
(Xie et al. 2008). Additionally, kV x-ray imaging can result in an added ionising radiation 
dose per fraction of 0.1 – 0.6 cGy (Bujold et al.  2012). While it  is recognised that the 
management  of  imaging  dose  during  radiation  therapy  is  a  different  problem  to 
management during diagnostic imaging (Murphy et al. 2007), it is important to evaluate all  
possible imaging technologies with a view to optimising the imaging frequency to improve 
therapeutic dose conformity.
Ultrasound (US) imaging is a potential  alternative method for providing high frequency 
positional  information  by  contour  (feature)  and  soft-tissue  (speckle)  tracking  during 
radiation therapy (Harris et al. 2007, Schlosser et al. 2011, Lediju Bell et al. 2012, Rubin et  
al.  2012,  Lachaine  and  Falco  2013).  US  imaging  is  non-ionising  and  non-invasive,  it  
provides soft tissue definition and has the ability to provide high frame (2D) or volume 
rates (3D).  US also negates the need to implant fiducial  markers which is an invasive 
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procedure with associated risks (Shinohara and Roach III 2008). US imaging has been 
implemented clinically for pre-treatment (inter-fraction) correction of prostate position using 
segmented prostate  contours.  The BAT® system (Best  Nomos,  PA,  USA)  uses trans-
abdominal ultrasound (TAUS) imaging to provide daily corrections to inter-fraction prostate 
variations by comparing the prostate position with the planning CT scan contour (Lattanzi 
et  al.  2000).  The  Clarity®  system (Elekta,  Stockholm,  Sweden)  provides  inter-fraction 
setup corrections adhering to the AAPM TG154 recommendation that US guidance should 
use US images as reference rather than CT, by integrating US at the patient simulation 
stage (Molloy et al. 2011). The Clarity device, which uses a 5 MHz 3D mechanically-swept 
probe, is being further developed to provide intra-fraction monitoring with images acquired 
via the perineum (TPUS) with a 2.5 second imaging period (Lachaine and Falco 2013). 
TPUS imaging allows visualisation of the prostate comparable with TAUS (Terris et  al.  
1998). In addition, it is advantageous as it does not require the acoustic window of a full 
bladder,  does not  interfere with the radiation beam path and provides a short  skin-to-
prostate distance.
A number of authors have investigated the use of ultrasound speckle (soft-tissue) tracking 
for image guided radiation therapy with promising results (Hsu et al. 2005, Harris et al.  
2007,  Lediju  Bell  et  al.  2012,  Rubin  et  al.  2012).  In  the  current  work,  we  perform a 
phantom-based study to evaluate the accuracy of mechanically-swept 3D-US (soft-tissue) 
speckle tracking for intra-fraction prostate motion management during radiation therapy. 
The  phantom,  implanted  with  fiducial  markers,  was  also  tracked  using  the  kV  x-ray 
imaging  system  on  CyberKnife  for  comparison.  US  motion  tracking  involved  off-line 
correlation-based tracking of the inherent speckle pattern in the RF ultrasound image data 
with dynamic phantom motion generated from in vivo Calypso prostate motion traces. To 
our knowledge, no previous publication has compared US speckle tracking with known 
input prostate motion. 
2. Materials and methods
2.1. Experimental set-up
An  ultrasound  phantom,  implanted  with  Tantalum  fiducials  was  translated  in  three 
dimensions  (3D)  using  a  motion  platform  to  simulate  realistic  prostate  motion.  The 
phantom was imaged using the kV x-ray system on CyberKnife and a 3D ultrasound (US)  
transducer (section 2.2) positioned to mimic trans-perineal imaging (an example of which 
is shown in figure 1 (a)). The centre of mass of at least 4 fiducials and US speckle pattern  
from the phantom (figure 1 (b)) were tracked. The experimental set-up is shown in figure 1 
(c). 
The motion platform employed three 1.8° step motors to translate the ultrasound phantom 
which was placed inside a 9 L water container. The US probe was positioned such that the 
axial,  lateral  and elevational  axes were aligned with the superior-inferior  (SI),  anterior-
posterior (AP) and right-left (RL) axes, respectively. The probe was fixed in place using a 
mechanical  articulated  arm  which  was  attached  to  the  treatment  couch.  Large  axial  
(superior-inferior)  translations necessitated the use of  water  as a coupling material  for 
ultrasound imaging. The ultrasound phantom was implanted with five Tantulum fiducial  
markers (diameter: 0.75 mm, length: 2.5 mm) to facilitate fiducial tracking using the x-ray 
imaging system. Fiducials  were implanted under  ultrasound guidance following fiducial 
placement requirement guidelines (Kee 2005).
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Cryogel (10%), a water soluble synthetic polymer, was used to fabricate the phantom due 
to it's long term stability and speed of sound (~ 1540 m s -1) comparable with human tissue 
(Surry et. al  2004).  Cellulose scatterer (0.25%) was added to the phantom to produce 
speckle.  The phantom was CT scanned with  1.5  mm slice  thickness at  120 kVp and 
maximum mAs for Cyberknife planning (MultiPlan).  The planning software generated a 
DRR with segmented fiducials. During simulated treatment, intra-fraction motion within a 
specified tracking range, was automatically compensated for by the treatment manipulator.  
Tracking data was output to a treatment log file. For this study we selected the minimum 
imaging interval  to provide the highest sampling of the prostate motion schemes. This 
resulted in a mean interval of 24.3 s between corresponding displacement data points.
2.2. Ultrasound system and 3D speckle tracking
A 3D RSP6-12 MHz probe (General Electric, CT, USA) interfaced to a Diasus US system 
(Dynamic Imaging) was used to acquire US data. The probe incorporates a mechanically-
swept 192-element wide-band linear array transducer with a centre frequency of 7.5 MHz 
and bandwidth of 5.0 MHz. It contains 192 elements and has a footprint of 5 cm (laterally)  
x 5.5 cm (elevationally). 3D data were acquired by sweeping (elevationally) the linear array 
through an angle θ. The central 128 elements of the probe were connected to the Diasus 
US system. Radio-frequency (RF) data were digitised and sampled at 66.67 MHz. The US 
imaging software Stradwin (Gee et al. 2004) was used to acquire 3D RF data.  While the 
probe's frequency may be higher than typically used for prostate imaging it was shown 
that,  despite high attenuation at depth, it  was possible to produce good quality  in vivo 
trans-perineal images of the prostate (figure 1 (a)).
An in-house MATLAB (Mathworks Inc.,  MA,  USA) 3D cross-correlation block-matching 
algorithm was used to track speckle incrementally in the US RF data. The code selects a 
reference volume or kernel in an initial ultrasound volume acquisition. A search volume of  
equal dimensions was selected within a user specified search region in a subsequently 
acquired US volume. The region was selected based on estimation of the magnitude and 
direction of motion. The code then calculates the 3D normalised correlation coefficient (3D 
NCC) between the reference and search volumes (Morsy and von Ramm 1998). The 3D 
NCC is calculated for all possible locations of the search volume within the search region.  
Finally the code calculates the peak in the 3D NCC by fitting a 1D Gaussian function to the  
spatial distribution of ρ values for each axis. The peak, ρmax,value gives an estimate of the 
inter-volume displacement of the tissue or phantom.
Since the probe acquires data using an angularly-swept linear array the axial, lateral and 
elevational  displacement  coordinates  are  given  in  polar  coordinates  of  r,  x  and θ 
respectively.  Conversion  of  cylindrical-polar  to  Cartesian  displacements  coordinates  is 
accomplished in the axial and elevational directions by:
                 (1)
                  (2)
It  is known that the accuracy of US displacement estimates decreases due to speckle 
decorrelation for  larger inter-volume displacements.  Additionally,  the main aim of intra-
fraction monitoring is to accurately detect small displacements before the target moves out  
of the planning-target-volume (PTV) margin. It was therefore important to ensure that the 
temporal resolution was high enough to limit the phantom motion between acquisitions (i.e 
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the inter-volume displacement) to a few millimetres. There is invariably a trade-off between 
elevational sweep angle, frame  density (i.e. frames per volume), volume rate and tracking 
accuracy (Harris et al. 2007). For a given sweep angle,  θ, the elevational field of view 
(FOVelev) was given by:
                (3)
where ROC = 78.0 mm. The optimal sweep angle and number of frames per volume were 
selected by varying the sweep angle from 5° to 20° and frames per volume from 10 to 50 
while imaging a 30 second segment of  persistent prostate motion (containing 3.3 mm 
(axial), 4.5 mm (lateral) and 0.5 mm (elevational) displacements). A sweep angle (θ) of 5º 
and 10 frames per  volume gave the  best  trade off  between  FOVelev,  volume rate  and 
tracking accuracy (volume period: 0.59 s, mean correlation: 0.88±0.02, RMSE: < 0.4 mm,). 
The US acquisition imaging depth and width was 64.4 mm and 25.0 mm, respectively. As 
described below, two types of motion were evaluated: (i) step-and-shoot and (ii) dynamic.  
For step-and-shoot displacements, 5 US volumes were taken per displacement (section 
2.3). For the dynamic (prostate) motion studies, 102 volumes of US data were acquired. A 
single US focus was positioned at a depth of ~15.0 mm in the phantom. 3D-US data was 
acquired by repeatedly sweeping the US transducer in a single direction. The elevational 
reference  volume side  length  was  varied  from 2  to  7  and  the  resultant  displacement 
estimate  was  compared  with  known inter-volume displacements  of  1  mm and  2  mm, 
respectively. The optimal reference volume used in the 3D-US speckle tracking code was 
45 (axial)  × 40 (lateral) × 3 (elevational) voxels. The optimal search region was (200 to 
900) × (50 to 90) × 3 in the axial (SI), lateral (AP) and elevational (RL) axis, respectively.
2.3. Input motion
2.3.1. Step-and-shoot displacements
The motion tracking capabilities of the US system were investigated with the phantom 
stationary and for both step-and-shoot displacements and dynamic prostate motion. The 
motion platform was used to translate the phantom by displacements of 0.1 – 5.0 mm. Five 
US volumes and a x-ray image set were acquired at each position. This helped elucidate 
the intrinsic accuracy of the US transducer in the absence of motion at acquisition time 
and of each axis independently. The estimated precision of motion platform translation was 
~0.1  mm superior-inferior  (axial)  and  ~0.05  mm anterior-posterior  /  right-left  (lateral  / 
elevational).  These values were estimated based on the motor  encoder  outputs  when 
returning to the same position 10 times for each axis independently.
2.3.2. Prostate motion data
Prostate  motion  data  from the  Calypso electro-magnetic  tracking  system was used to 
investigate the ability of US to track dynamic tissue motion. 480 intra-fraction motion traces 
(sampled at  10  Hz)  from 22  patients  were  analysed.  The system output  intra-fraction 
centre-of-mass  translations  only.  A  MATLAB  code  was  written  to  calculate:  (i)  the 
maximum, mean and standard deviation in centre-of-mass displacement along each axis,  
(ii) the percentage of fractions with ≥ 2 mm, ≥ 3 mm and ≥ 5 mm displacements and (iii) 
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the percentage of total tracking time with ≥ 2 mm, ≥ 3 mm and ≥ 5 mm displacements for 
each patient. Motion traces for all patients were also categorised into the following motion 
types: 
(i) stable (i.e. displacements remain within user-specified limits i.e. ± 2 mm),
(ii) transient  (i.e. displacements exceed user-specified limits but returns within limits  
before the end of the treatment fraction),
(iii) persistent excursions including continuous target drift  (i.e. displacements exceed 
user-specified limits and remains outside limits at end of fraction).
Knowledge of  the generalised motion along each axis  aided selection of  the optimum 
alignment of the US probe and patient axes. Since prostate motion along the AP and SI  
axes is the most clinically significant, it is important that these axes are tracked with the 
highest possible accuracy. For trans-perineal imaging, the axial axis is aligned with patient 
SI axis. The least accurate US axis (elevational axis) was then aligned with the patient axis 
exhibiting the least amount of motion (RL axis). Five Calypso motion traces, representative 
of all  types of prostate motion, were selected and used to generate input files for the 
motion  platform.  A 60  s  section  of  the  data  was  used  to  drive  the  motion  platform  / 
phantom while imaging with 3D-US and the kV x-ray system.
2.4. Data analysis
Differences  between  fiducial  marker  and  ultrasound  displacements  were  analysed  by 
calculating the root-mean-square error (RMSE) relative to the known input displacements 
of the motion platform for each axis (equation 4) and in 3D (by quadrature addition). Bland-
Altman 95% limits of agreement (LOA) analysis was also used to determine if fiducial and 
3D-US displacement estimates could be used interchangeably (Bland and Altman 1986). 
The  LOA gives  the  range  over  which  95%  of  the  differences  between  fiducial  and 
ultrasound  displacements  lie.  Differences  between  fiducial  and  US  displacements  of 
greater  than 2.0  mm were  considered to  be  clinically  unacceptable.  Therefore  a  LOA 
greater than  ±  2.0 mm indicated US could not replace fiducial markers for displacement 
estimation. For RL (elevational) displacements, RMSE and LOA analysis was limited to 
displacements of ≤ 2.0 mm. This was justified since the trade-off between field-of-view and 
volume rate  meant  that  large RL displacements  could  not  be  tracked accurately  and,  
additionally, RL prostate motion is small. Since out-of-plane motion is improbable, we also 
quantified the accuracy of 2D ultrasound tracking (2D – US).
                (4)
For prostate motion tracking analysis,  the input  motion data were interpolated into the 
fiducial or US tracking points prior to calculation of RMSE. Fiducial and 2D - US tracking 
data was time stamped and synchronised to within ± 1 s. Temporal calibration (alignment) 
of input motion and tracking data was achieved by minimising the RMSE between the 
input and axial 2D - US tracking data (which produced the most accurate sampling of the 
input  data).  It  was  estimated  that  a  1  s  error  in  temporal  calibration  could  lead  to  
uncertainties in RMSE values of ± 0.1 mm.
Motion tracking may be used to  determine if  the target  has reached a predetermined 
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displacement threshold, TVD, at which point the treatment may be paused until the target 
is repositioned via a couch shift (i.e. gating). Therefore the ability of US to detect when 
specified TVD value of 2.0 mm or 5.0 mm were also assessed for each of the prostate 
motion traces.
2.5. Correlation threshold value, TVC
The correlation coefficient indicates the degree of similarity between the reference volume 
before and after a displacement. A low correlation value is one of a number of potential  
metrics used to infer that the probability that the tracking code has correctly calculated the 
inter-volume displacement is low (Morsy and von Ramm 1999).  A study was therefore 
conducted using  the present  data  to  determine if  it  was possible  to  use a  correlation 
threshold  to  filter  out  inaccurate inter-volume displacement  estimates and improve the 
tracking  performance  in  certain  situations.  A  correlation  threshold,  TVC,  was 
retrospectively applied to the 3D-US prostate motion tracking data. This was accomplished 
by comparing each inter-volume peak correlation coefficient ρmax value with the TVC value 
and if ρmax < TVC then the corresponding incremental displacement estimate was excluded 
(i.e. set to 0.0 mm) from the cumulative (centre-of-mass) displacement estimate. The effect 
of applying TVC  values of 0.2 – 0.8 (in 0.05 increments) was quantified by calculating 
RMSE between the US tracked data and motion platform input motion. This method could 
potentially be adapted for use with real patient data.
2.6. Planning-target-volume margins
The method of Van Herk et al. (2000) was used to determine appropriate PTV margins in  
both  the  absence  and  presence  of  US  tracking.  The  systematic  and  random  errors 
associated  with  input  Calypso  prostate  motion  (no  intra-fraction  tracking)  and  3D-US 
tracking (intra-fraction tracking) were assessed and PTV margins calculated using:
                (5)
where  Σ and σ' represent the standard deviation and RMS of all systematic and random 
errors, respectively, added in quadrature. The margin calculation assumed a 2.0 mm x-ray 
fiducial residual set-up (inter-fraction) error (Mageras and Mechalakos 2007).
3. Results
3.1  Step-and-shoot displacements
The  ability  of  3D-US  to  estimate  known  phantom  translations  was  investigated  for 
displacements of 0 – 5 mm. The phantom was imaged while stationary to investigate the 
influence  of  noise  and  potential  elevational  positioning  errors  on  correlation  and 
displacement estimates. The mean correlation across five stationary US image volumes 
was 0.960  ±  0.003. Table 1 lists the mean correlation (for US speckle tracking), mean 
differences and RMSE of phantom displacements. US displacements compared well with 
fiducial displacement estimates in most cases. US estimated SI (axial) and AP (lateral)  
displacements  had  lower  RMSE  than  x-ray  fiducial  estimates  in  all  cases.  The  US 
elevational  field  of  view (FOVelev)  was limited by the need to  optimise volume rate for 
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tracking dynamic (prostate) motion so there was an inability to track large (5.0 mm) inter-
volume displacements.  The US elevational  axis  suffered from the  largest  inter-volume 
decorrelation (mean: 0.558) and exhibited the largest RMSE. The maximum elevational 
US tracking (RMS) error was 2.24 (± 0.06) mm. For x-ray tracking, the RMSE was ≤ 0.23 
(± 0.07) mm in all cases. Unlike US, there was negligible increase in RMSE when 5.0 mm 
displacements were included in the RMS error calculation (table 1). For displacements of 
up to 2 mm, the 3D RMSE was comparable for both kV x-ray (0.31) and 3D-US (0.25). 
When 5 mm displacements were included in the analysis the 3D RMSE increased to 2.25 
mm for 3D-US tracking (largely effected by elevational tracking errors).
The 3D-US and x-ray displacement estimates were plotted against input displacements 
and are shown in figure 2. Linear regression analysis resulted in r values of 0.999 for axial 
and lateral displacement comparisons. The analysis was restricted to displacements of ≤ 
2.0 mm for US elevational axis (r = 0.996). Bland-Altman 95% limits of agreement (LOA) 
was used to determine if US and fiducial displacements could be used inter-changeably, 
with a LOA larger than ±2.0 mm indicating that US and fiducials could not be used inter-
changeably. The LOA for axial and lateral displacements were ±0.15 mm and ±0.21 mm, 
respectively. The elevational LOA value (for displacements up to 2.0 mm) was ±0.18 mm, 
which also met the criterion for agreement.
3.2. Prostate motion data analysis
Analysis  of  480 intra-fraction motion traces showed the largest  component  of  prostate 
motion was along the AP axis. RL motion was minimal. The mean (± SD) displacement 
was  0.0 ± 0.3 mm,  0.0 ± 0.8 mm and  -0.1 ± 0.3 mm for RL, SI and AP axes, respectively.  
The maximum displacements were 2.1 mm (L), 10.3 mm (S) and 14.2 mm (A). Prostate 
motion was highly patient specific and generally rare with 17.9%, 10.8% and 6.9% of the 
total 480 fractions exhibiting displacements of ≥ 2 mm, ≥ 3 mm and ≥ 5 mm, respectively. 
However, some patient fractions showed large amplitude (> 10 mm) unpredictable motion. 
Seventeen (77.3%),  nineteen (86.4%) and twenty  two (100%) patients  exhibited  intra-
fraction displacements of < 2 mm, < 3 mm and < 5 mm for ≥ 95% of the total tracking time. 
For a threshold value of  ±  2 mm, 81.7 % of the 480 total fractions were categorised as 
stable while 7.9% exhibited persistent excursions or continuous drift. The remaining 10.4% 
showed transient excursions.
3.3. Prostate motion tracking
3D-US and x-ray fiducial tracking of prostate motion data is shown in figure 3. Qualitatively 
3D-US and x-ray tracking was in good agreement with input displacements. Some notable 
discrepancies remained for elevational (RL) 3D-US tracking (figure 3, right column). It was 
also apparent that the x-ray imaging frequency was non-uniform and relatively low, with 
only 2 – 4 data samples per motion scheme. Table 2 quantifies the RMSE of tracking with  
fiducials and 2D- and 3D- US. For each axis, the tracking RMSE was < 0.5 mm with 
several exceptions. For x-ray tracking the RMSE was 0.25 mm (SI), 0.26 mm (AP) and 
0.16 mm (RL), averaged over the five motion schemes. For 2D - US the RMSE was 0.44 
mm (SI) and 1.25 mm (AP), while 3D-US RMSE was 0.32 mm (SI), 0.51 mm (AP) and 
1.36 mm (RL), averaged over the five motion schemes. 
The high mean correlation values (mean: 0.964) for 2D - US indicated that out-of-plane 
motion was not a significant issue for prostate tracking in 2D. Conversely, the lower mean 
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correlation values (mean: 0.648) for 3D tracking were likely influenced by decorrelation 
along the elevational axis. The US tracking RMSE was lowest for axial (SI) displacements. 
The 2D-US RMSE was largely influenced by the error in tracking prostate motion scheme 
#5. This scheme exhibited the largest out-of-plane (elevational) motion, therefore imaging 
in 3D improved the RMSE. For the remaining four motion schemes the 2D - US (mean) 
tracking RMSE was 0.19 mm (SI) and 0.22 mm (AP) while for 3D-US was 0.34 mm (SI),  
0.44 mm (AP) and 0.66 mm (RL).  
Figure 4  shows a comparison of  3D-US and input  inter-volume displacements  for  the 
lateral  component  of  the  transient  motion  scheme.  It  can  be  seen  that  the  3D-US 
displacement estimates generally agree with input displacements to better than 0.5 mm 
with  only  three  excepts.  Figure  5  provides  analysis  of  the  differences  in  inter-volume 
displacements  for  all  five  motion  schemes.  It  was  found  that  98.4%  of  inter-volume 
displacements were within 0.5 mm of input values. This demonstrated that any differences 
between  input  motion  and  3D-US cumulative  (centre-of-mass)  displacement  estimates 
were due to  very few (1.6%) tracking errors.  A correlation threshold value (TVC) was 
investigated as  one method of  dealing  with  these errors  with  other  potential  methods 
presented in the discussion.
3D-US  tracking  could  be  used  to  monitor  the  target  position  until  it  has  reached  a 
predetermined displacement threshold, TVD (i.e gating the treatment). Therefore it is likely 
that the transient prostate motion scheme would trigger a treatment pause at some user-
specified  TVD  value.  The  treatment  would  then  resume  when  the  prostate  was 
repositioned within tracking limits. Figure 6 shows the RMSE as a function of TVD value 
for 3D-US tracking. For all motion schemes the maximum elevational (RL) displacement 
was  1.2  mm  and  therefore  this  axis  is  absent.  For  axial  (SI)  and  lateral  (AP) 
displacements,  the RMSE was < 0.2 mm and < 0.4 mm, respectively.  The error  bars 
represent the uncertainty in RMSE assuming a  ± 1 second error in temporal calibration 
between tracking data and input motion.
3.4. Correlation threshold value, TVC
For the 3D probe used in this study, tracking errors were most likely to occur along the 
elevational  axis  due  to  lower  spatial  resolution  and  effect  of  angular  decorrelation.  A 
correlation  threshold  was  applied  to  the  tracking  data  to  investigate  the  possibility  of 
improving  the  RMSE of  cumulative  displacement  estimates.  Figure  7  shows the  RMS 
tracking error as a function of correlation threshold (TVC: 0.2 – 0.8). This shows how the 
RMSE for the cumulative displacement trace is effected when incremental data points with 
associated inter-volume peak correlation values below TVC are set =0 mm. This simple 
method  appears  to  improve  the  3D  RMSE  when  the  cumulative  /  inter-volume 
displacement is small  (i.e. close to 0 mm) e.g. for  the stable motion scheme (min. 3D 
RMSE  for  TVC  =  0.8).  Investigating  each  axis  separately,  for  the  elevational  (RL) 
displacement  component,  it  can  be  seen  that  the  tracking  RMSE  improves  as  the 
correlation threshold increases. For TVC values above 0.75, the RMSE was less than 2.0 
mm. A correlation threshold was also applied to axial and lateral displacement components 
however this did not improve tracking accuracy  (i.e. For the five motion traces studied, 
when the correlation peak is low, an elevational inter-volume estimate = 0.0 mm is superior  
to displacement estimates calculated by the tracking code). Since analysis of 2D tracking 
results  showed that axial  (SI)  and lateral  (AP) displacements did not cause significant 
decorrelation (the minimum inter-volume correlation was 0.893 for all five prostate traces), 
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decorrelation in 3D tracking was likely due to elevational motion. Furthermore, plotting the 
minimum 2D peak correlation (2D tracking) against the maximum 3D elevational  inter-
volume displacement for the five motion schemes resulted in high Pearson correlation (-
0.803) further indicating that significant decorrelation (at this volume rate) is due to out-of-
plane (elevational) motion. Use of a correlation threshold will decrease the mean volume 
rate,  however,  for  elevational  (RL)  displacements  this  is  unlikely  to  be  an  issue  as 
discussed below. Figure 8 shows how elevational tracking RMSE can be improved for one 
of the prostate motion schemes.
3.5. Planning-target-volume margins
In the absence of US tracking, the required (anisotropic) PTV margins were 3.5 mm (SI),  
6.1 mm (AP) and 2.1 mm (RL). With the application of 3D-US tracking, the SI and AP PTV 
margins were decreased by -44.2% and -61.8% to 2.0 mm and 2.3 mm, respectively. Due 
to elevational tracking errors, the RL margin increased to 5.0 mm. However, by using a 
correlation threshold to remove erroneous inter-volume displacement estimates the RL 
margin could be reduced to 2.2 mm (TVC = 0.8). In the absence of tracking, an isotropic 
PTV margin (3D) of 7.5 mm was required. This was reduced to 6.1 mm (-18.5%) when  3D 
– US tracking was utilised.  The margin is largely effected by elevational  (RL) tracking 
errors.
4. Discussion
This study has investigated the use of mechanically-swept 3D ultrasound speckle tracking 
for prostate translations with knowledge of the input motion and comparison with currently 
available  intra-fraction  imaging  technology.  In  terms  of  imaging  rate,  US  is  clearly 
advantageous  (figure  3)  and  this  advantage  is  expected  to  improve  with  new  US 
technology  (Lediju  Bell  et  al.  2012).  For  simulated  trans-perineal  imaging,  ultrasound 
tracking exhibited the lowest RMSE for superior-inferior (axial) displacement estimates. 
The RMSE of anterior-posterior (lateral) displacements was also low (< 1.0 mm) in most 
cases.  Clinically,  axial  and  lateral  displacements  are  most  important  in  terms of  both 
displacement frequency and magnitude (Huang et  al.  2002).  Firstly,  the magnitude of 
motion along these axes can displace the prostate outside standard (~ 10 mm) and hypo-
fractionated  (~  3-  5  mm)  PTV margins.  Secondly,  it  is  desirable  to  limit  the  dose  to 
proximal  organs-at-risk  i.e.  the  bladder  (which  is  superior)  and  the  rectum  (which  is 
posterior).  When using a swept-array  probe it  is  important  to  align the most  accurate 
displacement tracking axis with the patient axis exhibiting the most clinically significant or 
relevant motion. 
The accuracy of the CyberKnife G4 fiducial tracking system has been reported to be 0.29 
±  0.10 mm (Antypas and Pantelis 2008). We found that the fiducial tracking RMSE was 
0.22 mm (mean) for our phantom based study. It is, however, important to note that the 
accuracy in tracking and beam targeting is highly dependent on the imaging frequency. As 
discussed below, the x-ray imaging system is likely to miss transient prostate excursions. 
For continuous target drift and persistent motion types x-ray tracking RMSE was 0.43 mm 
(mean (3D RMSE), max.: 0.91 mm). 3D – US tracking 3D RMSE was also found to be 
approximately a millimetre or less (mean: 0.93 mm, max.: 1.08 mm).
For  right-left  displacements,  there  was  a  trade-off  between  elevational  field-of-view 
(FOVelev), frame density and volume rate. One solution to this problem would be the use of 
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a 2D matrix array transducer which can acquire high resolution volumetric data at very 
high imaging rates without the need to sweep the transducer array along the elevational 
axis (Byram et al. 2010, Lediju Bell et al. 2012). In the current study it was also shown that 
the application of a simple correlation threshold to elevational (inter-volume) displacement 
estimates could improve the cumulative (centre-of-mass) displacement tracking. While this 
would reduce the effective mean volume rate this could also in the future be recovered 
using a high-volume rate 2D matrix transducer, which itself would improve correlation and 
tracking accuracy because inter-volume displacements would be smaller. In addition, and 
as  relevant  to  the  present  mechanically-swept  3D-US,  right-left  (elevational)  prostate 
motion generally involves low frequency, small  magnitude displacements (Huang et al. 
2002). An analysis of 3D-US inter-volume displacement estimates (figure 5) showed that  
discrepancies between input and 3D-US cumulative displacements (figure 3) was due to 
very  few  (<  2%)  large  (>  0.5  mm)  differences.  The  correlation  threshold  method 
investigated and discussed above is one quality metric which can be used to ensure the 
accuracy (i.e.  regularisation) of tracking data. Other methods could rely on analysis of 
temporal behaviour (e.g. filtering based on analysis of population motion characteristics) or 
spatial behaviour of the tissue or phantom (e.g. Lediju Bell et al. 2012).
Previous  studies  have  investigated the  use of  ultrasound for  prostate  motion  tracking 
during radiation therapy. Schlosser et al.  (2011) demonstrated the feasibility of using a 
telerobotic-based ultrasound imaging device. The system used correlation based tracking 
of trans-abdominal 2D – US data. A drop in the peak of the correlation coefficient was used 
as an indicator of potential rotations and out-of-plane motion. It was reported that in-plane 
(AP/SI)  prostate  translations,  rotations  and  out-of-plane  (RL)  translations  could  be 
detected  before  they  exceeded  2.5  mm,  5° and  2.8  mm,  respectively  (at  the  95% 
confidence level).  Rubin  et  al.  (2012)  evaluated 2D -  US speckle  tracking of  prostate 
motion  which  was  simulated  by  rocking  the  transducer  on  the  perineum.  Angular 
displacement of the prostate was found to be within 1.1° of that measured by manual 
tracking on B-mode images. These studies demonstrated the feasibility of 2D tracking of in 
vivo prostate  motion.  The current  study has extended this  to  3D tracking  with  known 
phantom prostate-derived motion.
It  is arguable whether 3D tracking is required for prostate motion. Our analysis of 480 
Calypso-tracked patient  fractions showed RL intra-fraction motion was small  (S.D.:  0.3 
mm, max.: 2.1 mm). Li et al. (2008) studied the dosimetric consequences of intra-fraction 
prostate motion and found that although significant motion can be observed in individual 
fractions, the dosimetric impact is insignificant during a typical course of therapy when 
PTV margins of  ≥ 2 mm are used with  pre-treatment localisation.  It  may therefore be 
feasible to track the prostate in 2D (using a 2.0 mm RL margin) reverting to 3D only when 
the inter-volume peak correlation drops below a specified threshold value (Schlosser et al. 
2011).  This would also allow tracking at a much higher imaging rate (frame rate).  The 
RMSE of 2D - US tracking was investigated and found to be < 0.5 mm for the stable and 
persistent  prostate  motion  traces  studied  (table  2).  While  the  RMSE  of  tracking  the 
transient motion trace increased (table 2), it is argued here and elsewhere (Lachaine and 
Falco  2013)  that  clinical  use  of  prostate  motion  tracking  is  generally  concerned  with 
compensating  for  drifts  and  persistent  excursions  rather  than  “chasing”  transient 
excursions. Also, using a 30 – 60 second imaging period, it is likely that the CyberKnife  
imaging system could “miss”  a transient  excursion (Xie et  al.  2008).  Furthermore,  the 
mean correlation for all 5 prostate motion traces studied was 0.964 confirming that out-of-
plane prostate motion was generally not an issue.
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The 3D-US system implemented in the current study could also be used for gating the 
treatment (Schlosser et al. 2011). The ability to treat prostate patients using very small 
margins and displacement thresholds has previously been investigated using the Calypso 
electromagnetic tracking system (Tropper et al. 2009). We have shown that 3D-US can 
accurately detect SI and AP displacement thresholds (TVD) of 2.0 and 5.0 mm (< 0.2 mm 
and < 0.4 mm RMSE) for the five selected motion traces (figure 6). A tracking threshold of 
2.0 mm could be used to treat patients with a 2.5 mm margin accounting for residual 
tracking errors. When a threshold value is detected, a treatment pause could be trigger. A 
correlation threshold could be applied to the elevational axis to improve RL displacement 
detection. The current study has not addressed intra-fraction prostate rotation (Aubry et al. 
2003). While generally smaller in magnitude (σ ≤ 1.8°) than inter-fraction motion, it may be 
important to account for rotation when considering the use of extremely small PTV margins 
or displacement thresholds. Finally, the tracking algorithm needs to operate in real-time. In 
the current study all ultrasound speckle-tracking was performed retrospectively and offline. 
Methods  of  increasing  tracking  speed  could  include  using  a  faster  method  of  block-
matching  (e.g.  a  parallelised  implementation  of  sum absolute  difference  (Mehta  et  al. 
2010))  and dynamic modification of  the search region based on previous inter-volume 
displacement estimates.
5. Conclusions
3D-ultrasound (US) speckle tracking has,  in general,  shown low RMSE (<0.5 mm) for 
intra-fraction prostate translation monitoring when compared to known phantom motion 
and kV x-ray fiducial tracking. US has a significantly higher imaging rate which may be 
important for hypo-fractionated treatments. For simulated trans-perineal imaging, superior-
inferior (axial) and anterior-posterior (lateral) tracking RMSE was better than 0.81 mm in all  
cases.  Right-left  (elevational)  tracking  suffered  from some erroneous  results  however, 
when inter-volume displacements are small,  it  was found that application of a speckle 
tracking correlation threshold could reduce the RMSE to < 2.0 mm. In the future, use of 
correlation  values  to  regularise  tracking  will  require  more  complex  methods  of 
extrapolation or weighted curve fitting of the displacement data to improve results for all 
motion types.  The largest US RMSE was for a high magnitude transient excursion. For 
continuous target drift and persistent motion types – which would likely have the largest 
dosimetric impact – the RMSE was sub-millimetre. 3D-US has potential for improvement 
for high tracking accuracy in all circumstances. 3D-US tracking was effective in reducing 
the  superior-inferior  and  anterior-posterior  treatment  margins  and  detecting  relevant 
centre-of-mass displacement thresholds. This phantom-based study has shown that 3D 
-US potentially has the accuracy needed to track prostate motion. It may be be feasible to 
track the prostate in 2D only. It would be insightful to study the ability of 2D/3D-US speckle 
tracking to  accurately  monitor  in  vivo motion  of  the prostate and account  for  prostate 
rotations.
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(a)       
(b)
(c)   (d)
Figure 1. Trans-perineal image of prostate (coronal view) with GE RSP6-12 MHz transducer (a). 
The green rectangle represents a possible reference (kernel) volume in one ultrasound volume 
acquisition.  The green rectangle in frame two is the best estimate of the position of the initial 
reference volume in a subsequent  US volume after  a cross-correlation search within  the blue 
rectangular region. Experimental set-up of phantom study (b) and transducer geometry showing 
trans-perineal alignment with patient axes (c).
Figure 2. Comparison of x-ray and 3D – ultrasound (US) estimated displacements with motion 
platform input displacements. The error bars give the standard deviation in displacement across 
the reference volume for the ultrasound displacement estimate and three measurements for  x-ray 
fiducial marker estimates.
Figure 3. Comparison of x-ray fiducial marker (FM) tracking, 3D – ultrasound (US) speckle tracking 
and input prostate motion schemes (from Calypso). The error bars give the standard deviation in 
FM displacement estimates. Each row gives the axial, lateral and elevational tracking of motion 
schemes 1 – 5 (as quantified in table 2).
Figure 4. Analysis of 3D-US inter-volume displacements for lateral component of transient motion 
scheme showing differences between interpolated input and 3D-US estimates.
Figure 5. Analysis  of  3D-US inter-volume displacements  showing  the number  of  inter-volume 
displacements with differences (3D-US – input) of 0.0 to ± 0.5 mm, ± 0.5 to ± 1.0 mm, ± 1.0 mm to 
± 1.5 mm and ± 1.5 mm to ± 2.0 mm, for each of the five motion schemes.
Figure 6. 3D-Ultrasound (US) tracking accuracy for displacement thresholds of 2.0 mm and 5.0 
mm demonstrating the accuracy with which 3D speckle tracking can detect when a cumulative 
displacement threshold has been reached. The inset figure demonstrates how the RMS error was 
calculated for a TVD = 5.0 mm example case.
Figure 7. 3D-Ultrasound (US) tracking RMS error as a function of correlation threshold (TVC) for 
axial  (a),  lateral  (b)  elevational  (c)  and  3D  (d)  estimates  of  prostate  motion  traces.  The  3D 
estimates RMSE have been normalised to one using the RMSE for original motion trace with no 
correlation  threshold  applied.  Therefore  a  RMSE  of  less  than  one  implies  the  corresponding 
correlation threshold value improves the RMSE. (circle: drift, square: persist. #1, diamond: persist. 
#2, triangle: stable, triangle left: transient). Linear regression lines to help guide the reader.
Figure  8. Example  of  accuracy  improvement  in  cumulative  displacement  when  a  correlation 
threshold (TVC) is applied to inter-volume elevational displacement estimates. Shown here for the 
right-left component of the persistent #1 prostate motion scheme (top). The correlation between 
consecutive ultrasound volumes  is also shown (bottom).
Table 1. Comparison of kV x-ray and 3D-ultrasound tracking with known input displacements of 0.2 
– 5 mm. Mean difference and root-mean-square error for displacements in the range of 0.2 – 2.0 
mm and 0.2 – 5.0 mm for  each of  the three major  axis  and 3D (axes combined).  The mean 
correlation (ρ) across the reference volume for the ultrasound tracking estimates and standard 
deviation for three x-ray measurements is also listed.
Direction Modality Mean diff. 
[mm]
RMSE 
(2mm) [mm]
RMSE 
(5mm) [mm]
SD 
[mm]
Mean ρ 
(2mm)
Mean ρ 
(5mm)
Axial / S-I US -0.15 0.14 0.15 - 0.831 0.766
X-ray 0.22 0.23 0.22 0.03 - -
Lateral / A-P US -0.15 0.12 0.17 - 0.744 0.685
X-ray -0.17 0.17 0.17 0.03 - -
Elevation / R-L US -0.14 0.17 2.24 - 0.558 0.447
X-ray -0.12 0.13 0.12 0.07 - -
All / 3D US 0.25 2.25
X-ray 0.31 0.30
Table 2. Root-mean-square errors for kV tracking and ultrasound 2D (axial and lateral frames only) 
and 3D incremental tracking of prostate motion traces. The mean correlation across the tracked 
ultrasound volume is also listed.
Motion RMSE [mm] Mean ρ
Axial / S-I Lateral / A-P Elev. / R-L All / 3D
KV x-ray
1 Con. drift 0.74 0.51 0.14 0.91 -
2 Persistent #1 0.10 0.17 0.18 0.27 -
3 Persistent #2 0.08 0.23 0.15 0.29 -
4 Stable 0.18 0.12 0.15 0.26 -
5 Transient 0.13 0.29 0.18 0.37 -
2D - US
1 Con. drift 0.17 0.18 0.17 0.30 0.967
2 Persistent #1 0.14 0.12 0.14 0.23 0.967
3 Persistent #2 0.35 0.37 0.12 0.52 0.950
4 Stable 0.09 0.22 0.12 0.27 0.969
5 Transient 1.47 5.34 0.65 5.58 0.967
3D - US
1 Con. drift 0.34 0.30 0.83 0.95 0.620
2 Persistent #1 0.30 0.22 0.69 0.78 0.649
3 Persistent #2 0.54 0.72 0.19 0.92 0.718
4 Stable 0.14 0.52 0.94 1.08 0.626
5 Transient 0.29 0.81 4.13 4.22 0.656
